Robert F. Kennedy Jr. remains firmly entrenched as HHS secretary, with the Trump administration actively elevating his role and MAHA agenda ahead of the midterms. Recent moves include new senior advisors to accelerate department priorities, loosened messaging controls, and public statements affirming his value to the president’s health agenda. Earlier speculation about a post-midterm exit has given way to explicit White House backing, including denials of departure rumors and Kennedy’s own emphasis on lasting institutional changes. Trader consensus at 96.5% for “No” reflects this stability, as no procedural, confirmation, or resignation signals point to an exit by October 31. Late developments such as a major policy reversal, health event, or presidential directive could still alter the timeline, though none have materialized in the current window.